OB-GYN expert testifies DHHS informational materials are medically accurate, urges routine coercion screening and clear patient education

An obstetrician-gynecologist testifying in a Michigan trial over state abortion information told the court that standardized patient-education materials used by the Department of Health and Human Services (DHHS) are medically accurate and support informed consent, and she urged routine screening for coercion and clear information about alternatives including parenting and adoption.

Dr. Monique Wubenhorst, an OB‑GYN and medical researcher, testified that she reviewed the DHHS materials admitted as evidence and the National Abortion Federation’s (NAF) clinical policy guidance and found them consistent with clinical practice. “I would say that they’re medically accurate,” Wubenhorst told the court during direct examination. She read aloud and cited the NAF policy statement that “a person must give voluntary, informed consent prior to an abortion,” and backed the documents’ descriptions of procedures and risks as neutral educational material.

Why it matters: The state DHHS materials are central to the dispute because Michigan’s reproductive‑health law requires patients seeking abortion to receive specified information in advance. How courts assess the materials’ medical accuracy and whether they facilitate—or impede—informed consent affects whether the state’s requirements survive constitutional scrutiny.

Key testimony and context

- On the content and tone: Wubenhorst said the DHHS descriptions of medication abortion, suction curettage and dilation-and-evacuation procedures align with clinical standards and with NAF guidance. She described the DHHS risk language for medication abortion (bleeding and cramping common; expect bleeding 9–16 days on average and possibly 30 days or more; death is a risk but “occurs in less than 1 of every 100,000 abortions”) as medically accurate and similar to standardized informed‑consent language she has used professionally. She testified, “No, I believe this is neutral,” when asked whether the DHHS wording appeared intended to bias decisions.

- On alternatives and fetal-development materials: Wubenhorst said disclosing alternatives to abortion—carry to term and parenting, or carry to term and pursue adoption—is consistent with NAF standards and ordinary clinical practice. She said fetal-development charts are medically accurate, commonly used in prenatal care, and can help patients understand gestational-age differences that affect pain and procedural choice.

- On ultrasound dating and procedure availability: The witness noted that clinic ultrasounds commonly include a dating margin (the consent form she reviewed said dating may range plus/minus two weeks) and that ultrasound dating cannot always establish gestational age to a single day. She testified that, on that basis, the 24-hour notice requirement alone would not, in her clinical judgment, change which procedures are available for a patient.

- On the 24-hour waiting period and informed consent: Wubenhorst drew a distinction between the statemandated 24‑hour delay and the clinician‑patient informed‑consent conversation. She said the process that typically facilitates a patient’s decision is the direct conversation with a clinician, not a statutory waiting period: “If a patient would like more time to think about something after having that conversation with their physician, that would certainly be acceptable and could even facilitate that decision making. But it’s not the state mandate of 24 hours that did that,” she testified.

- On pain, procedures and counseling: Drawing on clinical experience and literature, Wubenhorst told the court that medication abortion and surgical abortion have different risk profiles and pain experiences, and that patients benefit from being informed about possible need for surgical follow-up after medication abortion (she cited rates discussed in professional materials ranging from about 2–7 per 100 and up to 1 in 20 in some studies). She also described standardized materials and conversation as superior for knowledge retention compared with a form alone.

- On coercion screening: Wubenhorst emphasized coercion as an impediment to voluntary consent and supported proactive screening. She testified that screening protocols—such as the “Screening for Coercive Abortion, Intimate Partner Violence and Domestic Abuse” tool admitted at trial—are important: “Many women are coerced into abortion,” she said in describing clinical experience with trafficking and domestic abuse. She recommended steps including private screening, normalizing the screening questions and assessing immediate danger and safety planning when abuse is suspected.

- On crisis pregnancy centers and ultrasounds: Wubenhorst said, based on her interactions and webinars with some centers and review of websites, that some centers use licensed sonographers and have physicians review ultrasound impressions, although she acknowledged variation across facilities and limited, case‑by‑case familiarity in Michigan.

- On training and physician‑only debate: Wubenhorst identified differences in education and clinical exposure between board‑certified OB‑GYN physicians and advanced practice clinicians (APCs), saying APC programs are broader and historically have included less hands‑on surgical training and complication management than OB‑GYN residency. She said that managing potential catastrophic complications requires immediate surgical and hospital resources that may not be uniformly available in all settings.

Clarifying details cited at trial

- Medication abortion: expect bleeding or spotting for an average of 9–16 days, possibly 30 days or more; serious complications (including death) are rare; death cited as “less than 1 of every 100,000 abortions” in the materials she reviewed. - Ultrasound dating: clinic disclosures in evidence noted dating may be plus/minus two weeks. - Coercion screening: witness cited a 40% figure from a published study (Glander) about prevalence of domestic violence among patients presenting for abortion in some contexts; she used that to underscore the importance of screening but also discussed limits of generalization.

Speakers (attribution whitelist)

- Monique Wubenhorst — OB‑GYN expert witness (physician, medical researcher). Affiliation: practicing OB hospitalist; fellow, Center for Ethics and Culture at University of Notre Dame. - Seema G. Patel — Presiding judge. Affiliation: government (court). - Christopher Braverman — Assistant Attorney General (appeared for intervening defendant). Affiliation: government. - Megan Filly — Counsel for plaintiffs (appearance recorded). Affiliation: unknown (private counsel). - Rachel Miller — Counsel for plaintiffs (appearance recorded). Affiliation: unknown (private counsel). - (Generic labels used in transcript where a person was not clearly identified are omitted from attribution in article text.)

Authorities referenced in court

- policy: "National Abortion Federation Clinical Policy Guidelines for Abortion Care" (referred to in testimony; Exhibit A in court materials) - other: "Michigan DHHS patient information materials" (referred to in testimony; admitted as Exhibit 4) - statute: "Michigan constitutional amendment, reproductive freedom" (testimony acknowledged the amendment exists and limits state power) - other: Turnaway study and subsequent literature (discussed by witness and counsel)

Discussion vs. decision

- Discussion: The article summarizes testimony and debate about medical accuracy of the materials, clinical practice, coercion screening, ultrasound dating/margins of error, and the relative roles of clinicians versus statutory waiting periods in facilitating informed consent. - Decision/direction: No dispositive ruling on the merits of the law was reached in the portion of trial covered here; the article reports witness testimony and evidentiary argument.

Community relevance

- Geographies: Michigan (trial venue and law at issue); witness practice and examples also referenced North Carolina and Indiana clinical settings. - Impact groups: pregnant patients seeking abortion care; clinicians and clinic staff; victims of domestic violence and trafficking.

Provenance (transcript evidence)

- topicintro: {"block_id":"704.78503","local_start":0,"local_end":15,"evidence_excerpt":"State of Michigan court of public is now in session. Presiding, the honorable Seema g Patel, all persons having business here in, draw near, shall be heard.","reason_code":"topicintro"} - topfinish: {"block_id":"24681.645","local_start":0,"local_end":15,"evidence_excerpt":"Okay. Thank you very much. We are adjourned for the day, and I will see everyone here at 09:00 tomorrow.","reason_code":"topicfinish"}

Salience

- overall:0.75 - overall_justification: The trial examines whether state‑mandated patient information and related procedural requirements meet medical standards and constitutional limits; testimony from a practicing OB‑GYN can materially affect judicial assessment of medical accuracy and whether the law aids or impedes informed consent. - impact_scope:local - impact_scope_justification: The ruling will directly affect health care providers and patients in Michigan and may inform litigation or policy in other states. - attention_level:high - attention_level_justification: The transcript captures detailed expert testimony on a constitutionally charged subject (abortion access) during a public trial.

Engagement forecast

- newsworthiness: {"national":0.30,"regional":0.55,"local":0.85,"justification":"High local relevance; regional interest given national litigation trends; modest national pickup except in specialized outlets."} - notify_recommendation: {"audience":"state","reason":"Expert medical testimony and evidentiary disputes bear on state reproductive policy; notify state health officials, reproductive health reporters, legal desks.","audience_regions":["US-MI"],"justification":"Direct local legal stakes and medical implications for providers and patients."} - predicted_click_through:0.08 - predicted_read_time_minutes:3.2

Searchable_tags:["abortion","informed_consent","DHHS","NAF","coercion_screening","ultrasound","physician_only","APC_training","Michigan"]

graph_signals:{"jurisdictions":["US-MI"],"ontology_topics":["healthcare","reproductive_rights","court_case"],"entities":[{"id":"dr-monique-wubenhorst","name":"Monique Wubenhorst","type":"person"},{"id":"northland-family-planning","name":"Northland Family Planning Center","type":"organization"}],"events":[{"id":"northland-v-nessel-trial","name":"Northland Family Planning Center v. Nessel","date":"not specified"}]}